The Cell Growth and Differentiation (CGD) Program serves the Purdue University Center for Cancer Research as the central component for basic discovery in cancer cell biology. Since the last competitive renewal, membership in the program has grown from 17 to 26 members and includes 10 new, cancerfocused Assistant Professors and the new Center Director. United by a common goal to understand the molecular mechanisms governing the growth of cancer cells, CGD members are drawn from 7 Departments and 5 colleges from across the Purdue campus. The CGD Program has a strong record of publication, producing 260 papers since 2003 (12% collaborative). Program members attract approximately 6.5 million dollars of total peer-reviewed support per year, with 56% percent of the grants and 50% of the dollars awarded from the NCI, the Susan G. Komen Foundation, or the DOD breast and prostate cancer research programs. Those statistics reflect a 35% increase in cancer research dollars since the last competitive review. The CGD Program is structured around three major themes of discovery. Historically, the cornerstone of the CGD program has been its strength in cellular signaling with a distinguished group of senior and junior faculty. Many of these projects have spawned highly productive inter-programmatic collaborations involving members of the Chemistry and Structural Biology and Medicinal Chemistry Programs. The second discovery cluster encompasses the largest number of program participants and is focused on the control of gene expression in cancer cells. There is a growing emphasis on epigenetics and the role of chromatin modifications in gene silencing, which complements the focus of on tissue-specific transcription factors important in growth control decisions and development. The third discovery cluster, in which """"""""Animal Models of Cancer Development"""""""" is the theme, forms the newest and fastest growing area within the CGD Program.

Public Health Relevance

The program brings together scientists from various fields to address important cancer-related questions. Program leadership sets goals and encourages collaborations. Through the collaborative interactions important discovery are made, which will aid in reducing the pain and suffering caused by cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023168-33
Application #
8470558
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
33
Fiscal Year
2013
Total Cost
$4,699
Indirect Cost
$1,646
Name
Purdue University
Department
Type
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Morman, Rosemary E; Schweickert, Patrick G; Konieczny, Stephen F et al. (2018) BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice. Eur J Immunol 48:1492-1505
Zhang, Zhuangzhuang; Cheng, Lijun; Li, Jie et al. (2018) Inhibition of the Wnt/?-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Res 78:3147-3162
Rangasamy, Loganathan; Chelvam, Venkatesh; Kanduluru, Ananda Kumar et al. (2018) New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. Bioconjug Chem 29:1047-1059
Zhang, Hao; Zhang, Yanqiu; Zhu, Xiaoyun et al. (2018) DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology :
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112
Dhawan, Deepika; Hahn, Noah M; Ramos-Vara, José A et al. (2018) Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer. PLoS Genet 14:e1007571
Shinde, Aparna; Libring, Sarah; Alpsoy, Aktan et al. (2018) Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Mol Cancer Res 16:1579-1589
Ghosh, Arun K; Ghosh, Koena; Brindisi, Margherita et al. (2018) Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg Med Chem Lett 28:2605-2610
Thompson, Taylor J; Han, Bumsoo (2018) Analysis of adhesion kinetics of cancer cells on inflamed endothelium using a microfluidic platform. Biomicrofluidics 12:042215

Showing the most recent 10 out of 436 publications